Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
cinrebafusp alfa (PRS-343)
i
Other names:
PRS-343, PRS 343, HER2/41BB bispecific antibody
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(8)
News
Trials
Company:
Palvella Therapeutics, Servier
Drug class:
HER2 inhibitor, CD137 agonist
Related drugs:
‹
trastuzumab (407)
afatinib (227)
lapatinib (107)
neratinib (102)
pyrotinib (79)
tucatinib (39)
trastuzumab-pkrb (24)
margetuximab-cmkb (18)
poziotinib (17)
zenocutuzumab-zbco (16)
KN026 (14)
mobocertinib (12)
trastuzumab-dttb (11)
zanidatamab-hrii (11)
trastuzumab-strf (9)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
D3L-001 (7)
inetetamab (6)
ASLAN001 (6)
BDTX-189 (5)
AEE788 (4)
MT-5111 (4)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
MET306 (4)
GNP101 (3)
pertuzumab/trastuzumab/hyaluronidase-zzxf (3)
sunvozertinib (3)
AST-301 (2)
Bay846 (2)
CT-0508 (2)
DF1001 (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
VIR-5818 (2)
BDC-1001 (2)
ACE1702 (1)
Hercease (trastuzumab biosimilar) (1)
BAY2701439 (1)
DZD1516 (1)
GCC2003 (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
EG12014 (trastuzumab biosimilar) (1)
sevabertinib (1)
IAH0968 (1)
MP0274 (1)
Paletan (pertuzumab biosimilar) (1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
RT1978 (1)
ABL105 (1)
RG6596 (1)
KD019 (1)
IMM2902 (1)
ABT-101 (0)
ADG138 (0)
ALT02 (trastuzumab biosimilar) (0)
trastuzumab biosimilar (AP062) (0)
B-Vaxx (0)
BAT1006 (0)
BAY2701438 (0)
BMS690514 (0)
CAM-H2 (0)
CAT-179 (0)
CUDC-101 (0)
DA 3111 (trastuzumab biosimilar) (0)
EG1206A (pertuzumab biosimilar) (0)
ELVN-002 (0)
ES2B-C001 (0)
ETBX-021 (0)
Faceptor (trastuzumab biosimilar) (0)
GB235 (0)
HER-2/neu peptide vaccine (0)
HER2 t-haNK (0)
HF158K1 (0)
Hervycta (trastuzumab biosimilar) (0)
ISB 1302 (0)
JNJ-26483327 (0)
diznalimgene lisbac (0)
MBS301 (0)
MM 111 (0)
MP412 (0)
MVA-BN-HER2 (0)
NVL-330 (0)
NeuCeptin (trastuzumab biosimilar) (0)
nelipepimut-S (0)
lapuleucel-T (0)
OS47701 (0)
pertuzumab-dpzb (0)
QP34563457 (0)
ertumaxomab (0)
trastuzumab biosimilar (SIBP-01) (0)
SPH5030 (0)
SSGJ-705 (0)
SYSA1901 (pertuzumab biosimilar) (0)
Sym013 (0)
TAC100-HER2 (0)
TAK-285 (0)
TAS0728 (0)
TPIV100 (0)
TQB2930 (0)
glycooptimized trastuzumab-GEX (0)
TrastuRel (trastuzumab biosimilar) (0)
Undisclosed HER2Bi-armed ATC (0)
VM 206 (0)
YH42946 (0)
AST1306 (0)
cipatinib (0)
dHER2+AS15 (0)
IBI315 (0)
KBP-5209 (0)
RG6194 (0)
AZD8931 (0)
trastuzumab biosimilar (0)
trastuzumab biosimilar (0)
TJ-CD4B (4)
ALG.APV-527 (1)
HK013 (1)
Opal (1)
PF-08046049 (1)
PM1003 (1)
GNC-035 (1)
PF-05082566 (1)
ABL102 (0)
ABL103 (0)
ADG106 (0)
AGEN2373 (0)
AP203 (0)
ASP1002 (0)
BCY11864 (0)
BGB-B167 (0)
BI 765179 (0)
BNA035 (0)
BOS-342 (0)
BT7455 (0)
BT7480 (0)
CB307 (0)
CD137 mAb (0)
DSP-107 (0)
EU101 (0)
EU204 (0)
EU210 (0)
EU211 (0)
FS120 (0)
FS222 (0)
GNC-039 (0)
HBM7008 (0)
HK010 (0)
LM-24C5 (0)
MCLA-145 (0)
MP0310 (0)
NM21-1480 (0)
OC-001 (0)
PM1032 (0)
QL301 (0)
RG7827 (0)
RTX-224 (0)
RTX-240 (0)
RTX-321 (0)
SAIL66 (0)
STA551 (0)
GEN1046 (0)
RG6524 (0)
GNC-038 (0)
RG6076 (0)
INBRX-105 (0)
LVGN6051 (0)
ABL503 (0)
GEN1042 (0)
BMS-663513 (0)
ATG-101 (0)
trastuzumab (407)
afatinib (227)
lapatinib (107)
neratinib (102)
pyrotinib (79)
tucatinib (39)
trastuzumab-pkrb (24)
margetuximab-cmkb (18)
poziotinib (17)
zenocutuzumab-zbco (16)
KN026 (14)
mobocertinib (12)
trastuzumab-dttb (11)
zanidatamab-hrii (11)
trastuzumab-strf (9)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
D3L-001 (7)
inetetamab (6)
ASLAN001 (6)
BDTX-189 (5)
AEE788 (4)
MT-5111 (4)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
MET306 (4)
GNP101 (3)
pertuzumab/trastuzumab/hyaluronidase-zzxf (3)
sunvozertinib (3)
AST-301 (2)
Bay846 (2)
CT-0508 (2)
DF1001 (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
VIR-5818 (2)
BDC-1001 (2)
ACE1702 (1)
Hercease (trastuzumab biosimilar) (1)
BAY2701439 (1)
DZD1516 (1)
GCC2003 (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
EG12014 (trastuzumab biosimilar) (1)
sevabertinib (1)
IAH0968 (1)
MP0274 (1)
(1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
RT1978 (1)
ABL105 (1)
RG6596 (1)
KD019 (1)
IMM2902 (1)
ABT-101 (0)
ADG138 (0)
ALT02 (trastuzumab biosimilar) (0)
trastuzumab biosimilar (AP062) (0)
B-Vaxx (0)
BAT1006 (0)
BAY2701438 (0)
BMS690514 (0)
CAM-H2 (0)
CAT-179 (0)
CUDC-101 (0)
DA 3111 (trastuzumab biosimilar) (0)
(0)
ELVN-002 (0)
ES2B-C001 (0)
ETBX-021 (0)
(0)
GB235 (0)
HER-2/neu peptide vaccine (0)
HER2 t-haNK (0)
HF158K1 (0)
Hervycta (trastuzumab biosimilar) (0)
ISB 1302 (0)
JNJ-26483327 (0)
diznalimgene lisbac (0)
MBS301 (0)
MM 111 (0)
MP412 (0)
MVA-BN-HER2 (0)
NVL-330 (0)
NeuCeptin (trastuzumab biosimilar) (0)
nelipepimut-S (0)
lapuleucel-T (0)
OS47701 (0)
pertuzumab-dpzb (0)
QP34563457 (0)
ertumaxomab (0)
trastuzumab biosimilar (SIBP-01) (0)
SPH5030 (0)
SSGJ-705 (0)
(0)
Sym013 (0)
TAC100-HER2 (0)
TAK-285 (0)
TAS0728 (0)
TPIV100 (0)
TQB2930 (0)
glycooptimized trastuzumab-GEX (0)
TrastuRel (trastuzumab biosimilar) (0)
Undisclosed HER2Bi-armed ATC (0)
VM 206 (0)
YH42946 (0)
AST1306 (0)
cipatinib (0)
dHER2+AS15 (0)
IBI315 (0)
KBP-5209 (0)
RG6194 (0)
AZD8931 (0)
trastuzumab biosimilar (0)
trastuzumab biosimilar (0)
TJ-CD4B (4)
ALG.APV-527 (1)
HK013 (1)
Opal (1)
PF-08046049 (1)
PM1003 (1)
GNC-035 (1)
PF-05082566 (1)
ABL102 (0)
ABL103 (0)
ADG106 (0)
AGEN2373 (0)
AP203 (0)
ASP1002 (0)
BCY11864 (0)
BGB-B167 (0)
BI 765179 (0)
BNA035 (0)
BOS-342 (0)
BT7455 (0)
BT7480 (0)
CB307 (0)
CD137 mAb (0)
DSP-107 (0)
EU101 (0)
EU204 (0)
EU210 (0)
EU211 (0)
FS120 (0)
FS222 (0)
GNC-039 (0)
HBM7008 (0)
HK010 (0)
LM-24C5 (0)
MCLA-145 (0)
MP0310 (0)
NM21-1480 (0)
OC-001 (0)
PM1032 (0)
QL301 (0)
RG7827 (0)
RTX-224 (0)
RTX-240 (0)
RTX-321 (0)
SAIL66 (0)
STA551 (0)
GEN1046 (0)
RG6524 (0)
GNC-038 (0)
RG6076 (0)
INBRX-105 (0)
LVGN6051 (0)
ABL503 (0)
GEN1042 (0)
BMS-663513 (0)
ATG-101 (0)
›
Associations
(8)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
PRS-343
Sensitive: C2 – Inclusion Criteria
PRS-343
Sensitive
:
C2
PRS-343
Sensitive: C2 – Inclusion Criteria
PRS-343
Sensitive
:
C2
HER-2 positive
Gastric Cancer
HER-2 positive
Gastric Cancer
PRS-343
Sensitive: C2 – Inclusion Criteria
PRS-343
Sensitive
:
C2
PRS-343
Sensitive: C2 – Inclusion Criteria
PRS-343
Sensitive
:
C2
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
HER-2 positive
Gastroesophageal Junction Adenocarcinoma
PRS-343
Sensitive: C2 – Inclusion Criteria
PRS-343
Sensitive
:
C2
PRS-343
Sensitive: C2 – Inclusion Criteria
PRS-343
Sensitive
:
C2
HER-2 positive
Colorectal Cancer
HER-2 positive
Colorectal Cancer
PRS-343
Sensitive: C3 – Early Trials
PRS-343
Sensitive
:
C3
PRS-343
Sensitive: C3 – Early Trials
PRS-343
Sensitive
:
C3
HER-2 positive
Biliary Tract Cancer
HER-2 positive
Biliary Tract Cancer
PRS-343
Sensitive: C3 – Early Trials
PRS-343
Sensitive
:
C3
PRS-343
Sensitive: C3 – Early Trials
PRS-343
Sensitive
:
C3
HER-2 positive
Urothelial Cancer
HER-2 positive
Urothelial Cancer
PRS-343
Sensitive: C3 – Early Trials
PRS-343
Sensitive
:
C3
PRS-343
Sensitive: C3 – Early Trials
PRS-343
Sensitive
:
C3
HER-2 positive
Pancreatic Cancer
HER-2 positive
Pancreatic Cancer
PRS-343
Sensitive: C4 – Case Studies
PRS-343
Sensitive
:
C4
PRS-343
Sensitive: C4 – Case Studies
PRS-343
Sensitive
:
C4
HER-2 positive
Melanoma
HER-2 positive
Melanoma
PRS-343
Sensitive: C4 – Case Studies
PRS-343
Sensitive
:
C4
PRS-343
Sensitive: C4 – Case Studies
PRS-343
Sensitive
:
C4
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.